GSK logo

Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, RSV Vaccines

GSK

London, England, United Kingdom; Wavre, Wallonia, Belgium; Upper Providence, Pennsylvania, United StatesHybridPosted 16 days agoEUR 151,500 - EUR 252,500
Full TimeDirector & AboveResearch & ScientistPharmaceutical
Original posting ↗

Summary

The CPO organisation partners closely with R&D and Commercial to translate cutting-edge science into measurable health outcomes, grounded in the patient voice and external insights from healthcare systems and decision-makers worldwide. Joining CPO means working across the full product lifecycle and collaborating with diverse expert teams – from Patients & External Environment and Medical Planning to Data Generation, Scientific Communications, Medical Impact, Proactive Risk Ownership and Integrated Evidence Strategy – to ensure robust evidence, clear medical insight and responsible risk ownership shape strategy and execution at scale.

Job description

The role of Senior Director, Global Real-World Evidence & Health Outcomes Research (GRWE& HO) Lead is critical to achieving this ambition by ensuring that each vaccine GSK brings to market is supported by scientifically credible, high-quality evidence that drives competitiveness and strong evidence-based product positioning, value propositions and value-based pricing. The role is essential for the alignment of evidence with the requirements of customers responsible for marketing authorization, recommendation and reimbursement leading to successful patient access, product use and commercial success. The role will serve as single point accountable lead for RSV vaccines, including stand alone and combination assets, in market and pre-launch. The role will be a key member of the Global Real-World Evidence & Health Outcomes Research Vaccines LT and other relevant matrix leadership teams.

Key Responsibilities

  • Provide leadership, management, and development of Data Generation book of work.
  • Partner effectively with matrix stakeholders in planning and design of the DGP for the asset, drive disciplined execution of studies and activities, translate results, and disseminate data and research findings to all relevant internal and external stakeholders.
  • Provide scientific leadership for best practice in real world evidence study methodologies, leveraging diverse methodological approaches to meet unique product challenges with innovative evidence solutions.
  • Drive innovation and inform ideas and options through effective engagement with external experts, clinical guideline groups, HTA agencies, methodology and policy forums, and by leveraging knowledge of the external policy and decision maker environment to enable more efficient evidence development for the asset across the lifecycle (e.g. discovery, launching and life cycle management assets).
  • Integrate excellent understanding of the evolving global NITAG bodies, clinical guidelines groups, policy decision makers and payer environment, including recommendation, reimbursement, pricing, and access associated with vaccines.
  • Lead discussions with key stakeholders on prioritization of evidence generation in order to meet business and customer needs.
  • Deliver the materials to inform internal governance decision making (e.g. Medical Review Board, etc).
  • Facilitate alignment and partnership to enable more effective interactions within the complex stakeholder matrix, e.g. clinical, commercial, market access, medical affairs functions, priority market LOCs as well as external third-party suppliers.
  • Represent GSK in external collaborations, engagement and scientific evidence requirements with scientific partners, reimbursement bodies and other decision makers.
  • Drive quality and compliance through team to ensure trust for the evidence that is delivered.
  • Drive discipline in performance reporting and ensure studies are delivered according to plan and within budget.

Basic Qualifications

  • PhD or DPhil (or equivalent) in epidemiology, health economics, health outcomes, patient-reported outcomes, health, or life sciences.
  • Considerable experience in the pharmaceutical industry in Vaccines, in a leadership role with line management responsibility.
  • Strong business acumen, with the ability to translate customer needs into an actionable data generation plan.
  • Methods expertise to guide and lead the team in delivering robust evidence outputs, and the credibility to engage meaningfully with external experts and leaders in the field.
  • Knowledge of the diversity and complexity of vaccine access landscapes, healthcare markets, health technology assessment agencies, and reimbursement decision-making globally, regionally, and in local markets.
  • Deep knowledge and strong communication skills to interpret and translate complex concepts and results effectively for a variety of audiences, influencing decision-making.
  • Deep knowledge of vaccine development and access pathways.
  • Self-motivated, able to work independently and build credibility with colleagues across the enterprise.
  • Experience leading a complex portfolio of projects, stakeholders, and analytic staff in a senior role.

Preferred Qualifications

  • Advanced scientific degree such as PharmD in specialized in Vaccine.
  • Experience in above country and in country roles.
  • Experience in vaccines launches at the global level, and/or introductions at the local level.
  • Experience supporting assets in with complex competitor landscapes.
  • Portfolio of high value publications and/or scientific promotions.

Requirements

  • PhD or DPhil (or equivalent) in epidemiology, health economics, health outcomes, patient-reported outcomes, health, or life sciences.
  • Considerable experience in the pharmaceutical industry in Vaccines, in a leadership role with line management responsibility.
  • Strong business acumen, with the ability to translate customer needs into an actionable data generation plan.
  • Methods expertise to guide and lead the team in delivering robust evidence outputs, and the credibility to engage meaningfully with external experts and leaders in the field.
  • Knowledge of the diversity and complexity of vaccine access landscapes, healthcare markets, health technology assessment agencies, and reimbursement decision-making globally, regionally, and in local markets.
  • Deep knowledge and strong communication skills to interpret and translate complex concepts and results effectively for a variety of audiences, influencing decision-making.
  • Deep knowledge of vaccine development and access pathways.
  • Self-motivated, able to work independently and build credibility with colleagues across the enterprise.
  • Experience leading a complex portfolio of projects, stakeholders, and analytic staff in a senior role.
  • Advanced scientific degree such as PharmD in specialized in Vaccine.
  • Experience in above country and in country roles.
  • Experience in vaccines launches at the global level, and/or introductions at the local level.
  • Experience supporting assets in with complex competitor landscapes.
  • Portfolio of high value publications and/or scientific promotions.

Benefits

  • Annual bonus
  • Share based long term incentive program

Company overview

GSK plc (formerly GlaxoSmithKline) is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has grown to become one of the world's leading healthcare companies with operations in over 150 countries. The company specializes in researching, developing, and manufacturing prescription medicines, vaccines, and consumer healthcare products. GSK's therapeutic areas include respiratory diseases, HIV/AIDS, oncology, immunology, and infectious diseases. The company is particularly renowned for its vaccine portfolio and has been at the forefront of developing treatments for major global health challenges. With approximately 70,000 employees worldwide, GSK maintains a strong commitment to scientific innovation and has a significant presence in key markets including the United States, Europe, and emerging economies. The company's mission is to unite science, technology, and talent to get ahead of disease together, aiming to positively impact the health of 2.5 billion people by the end of the decade.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.